title: Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect?
abstract: BACKGROUND
  Few data exist about the incidence of drug-induced pancreatitis in the general population. Drugs are related to the etiology of pancreatitis in about 1.4-2% of cases. While statins are generally well tolerated they have been known to be associated with pancreatitis. Acute pancreatitis has been reported in a few cases treated with atorvastatin, fluvastatin, lovastatin, simvastatin and pravastatin.
  
  
  METHODS
  We report the case of a 77-year-old patient who developed acute pancreatitis after treatment with rosuvastatin, which resolved on withdrawal of the medication. She had a similar episode of pancreatitis a year ago precipitated by atorvastatin, which resolved on withdrawal. Extensive workup on both occasions failed to reveal any other etiology for the pancreatitis.
  
  
  CONCLUSIONS
  To our knowledge this is the first report of rosuvastatin-induced pancreatitis. The occurrence of pancreatitis with two different statins in our patient argues that statins induced pancreatitis may be a class-effect of statins. With statin prescriptions on the rise clinicians need to be aware of this complication of statin treatment and remember that the newest statin, rosuvastatin is not dissimilar to the other statins in causing pancreatitis.
authors.affiliation: Department of Internal Medicine, Unity Health System, Rochester, NY 14626, USA. ssingh@unityhealth.org
authors.forename: Sonal
authors.initials: S
authors.lastname: Singh
authors.forename: Amit
authors.initials: A
authors.lastname: Nautiyal
authors.forename: James G
authors.initials: JG
authors.lastname: Dolan
mesh_terms: D000208:Acute Disease; D000368:Aged; D000069059:Atorvastatin; D005260:Female; D005464:Fluorobenzenes / Q000009:adverse effects*; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D010195:Pancreatitis / Q000139:chemically induced*; D011743:Pyrimidines / Q000009:adverse effects*; D011758:Pyrroles / Q000009:adverse effects*; D012008:Recurrence; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D005464:Fluorobenzenes; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D011758:Pyrroles; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D000069059:Atorvastatin